文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

和均低表达作为成人肾上腺皮质癌新型负性预后标志物。

Low Protein Expression of both and as Novel Negative Prognostic Markers of Adult Adrenocortical Carcinoma.

机构信息

Unidade de Suprarrenal, Serviço de Endocrinologia e Metabologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 155, São Paulo 05403-900, Brazil.

Laboratório de Hormônios e Genética Molecular LIM/42, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 255, São Paulo 05403-900, Brazil.

出版信息

Int J Mol Sci. 2021 Jan 27;22(3):1238. doi: 10.3390/ijms22031238.


DOI:10.3390/ijms22031238
PMID:33513905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7866180/
Abstract

Adrenocortical carcinoma (ACC) is a rare malignancy that is associated with a dismal prognosis. Pan-genomic studies have demonstrated the involvement of and genes in adrenocortical tumorigenesis. Our aims were to evaluate the protein expression of and in a cohort of 82 adults with ACC and to establish their prognostic value. Two pathologists analyzed immuno-stained slides of a tissue microarray. The low protein expression of and was associated with a decrease in overall survival (OS) ( = 0.045, = 0.012, respectively). The Cox regression for protein expression of >1.5 showed a hazard ratio (HR) for OS of 0.521 (95% CI 0.273-0.997; = 0.049) when compared with ≤1.5; for expression >2, the HR for OS was 0.441 (95% CI, 0.229-0.852; = 0.015) when compared with ≤2. High and protein expressions were associated with optimistic recurrence-free survival (RFS) ( = 0.027 and = 0.005, respectively). The Cox regression of RFS showed an HR of 0.332 (95%CI, 0.111-0.932) for expression >2.7 ( = 0.037), and an HR of 0.333 (95%CI, 0.140-0.790) for expression >2 ( = 0.013). In conclusion, low protein expression of and are negative prognostic markers of ACC; however, different cohorts should be evaluated to validate these findings.

摘要

肾上腺皮质癌 (ACC) 是一种罕见的恶性肿瘤,预后不良。泛基因组研究表明 和 基因参与了肾上腺皮质肿瘤的发生。我们的目的是评估 82 例成人 ACC 患者的 和 蛋白表达,并确定其预后价值。两位病理学家分析了组织微阵列的免疫染色切片。 和 蛋白低表达与总生存(OS)降低相关( = 0.045, = 0.012)。 蛋白表达 >1.5 的 Cox 回归分析显示 OS 的危险比(HR)为 0.521(95%CI 0.273-0.997; = 0.049),与 ≤1.5 相比;对于 表达>2,OS 的 HR 为 0.441(95%CI,0.229-0.852; = 0.015),与 ≤2 相比。高 和 蛋白表达与乐观的无复发生存(RFS)相关( = 0.027 和 = 0.005)。RFS 的 Cox 回归分析显示, 表达>2.7 的 HR 为 0.332(95%CI,0.111-0.932)( = 0.037), 表达>2 的 HR 为 0.333(95%CI,0.140-0.790)( = 0.013)。总之, 和 蛋白低表达是 ACC 的负预后标志物;然而,应该评估不同的队列来验证这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3c/7866180/0e439aa52acd/ijms-22-01238-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3c/7866180/ad525cd66f89/ijms-22-01238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3c/7866180/683b9160c670/ijms-22-01238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3c/7866180/b3e6e2d2fd2a/ijms-22-01238-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3c/7866180/77d2bd38849b/ijms-22-01238-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3c/7866180/468e47c68e45/ijms-22-01238-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3c/7866180/ba62bcc8a768/ijms-22-01238-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3c/7866180/b51b63e6ff67/ijms-22-01238-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3c/7866180/71ddc38f09f7/ijms-22-01238-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3c/7866180/0e439aa52acd/ijms-22-01238-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3c/7866180/ad525cd66f89/ijms-22-01238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3c/7866180/683b9160c670/ijms-22-01238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3c/7866180/b3e6e2d2fd2a/ijms-22-01238-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3c/7866180/77d2bd38849b/ijms-22-01238-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3c/7866180/468e47c68e45/ijms-22-01238-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3c/7866180/ba62bcc8a768/ijms-22-01238-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3c/7866180/b51b63e6ff67/ijms-22-01238-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3c/7866180/71ddc38f09f7/ijms-22-01238-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd3c/7866180/0e439aa52acd/ijms-22-01238-g009.jpg

相似文献

[1]
Low Protein Expression of both and as Novel Negative Prognostic Markers of Adult Adrenocortical Carcinoma.

Int J Mol Sci. 2021-1-27

[2]
Prognostic Relevance of Steroid Sulfation in Adrenocortical Carcinoma Revealed by Molecular Phenotyping Using High-Resolution Mass Spectrometry Imaging.

Clin Chem. 2019-9-6

[3]
Prognostic Role of Ki-67 in Adrenocortical Carcinoma After Primary Resection: A Retrospective Mono-Institutional Study.

Adv Ther. 2019-8-30

[4]
Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.

JAMA Surg. 2016-4

[5]
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma.

J Clin Endocrinol Metab. 2017-9-1

[6]
Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma.

J Clin Endocrinol Metab. 2019-5-1

[7]
Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.

Ann Surg Oncol. 2015-12

[8]
Expression of the zinc-finger transcription factor Snail in adrenocortical carcinoma is associated with decreased survival.

Br J Cancer. 2008-12-2

[9]
Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.

Cancer Med. 2020-2

[10]
Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas.

Endocr J. 2008-3

引用本文的文献

[1]
Locking the gates of immortality: targeting alternative lengthening of telomeres (ALT) pathways.

Med Oncol. 2025-2-18

[2]
A Comprehensive Target Panel Allows to Extend the Genetic Spectrum of Neuroendocrine Tumors.

Neuroendocrinology. 2025

[3]
A Clinicopathological Analysis of Asian Patients with Adrenocortical Carcinoma: A Single-Center Experience.

Curr Oncol. 2023-4-8

[4]
Retrospective Analysis of Prognostic Factors in Pediatric Patients with Adrenocortical Tumor from Unique Tertiary Center with Long-Term Follow-Up.

J Clin Med. 2022-11-9

[5]
Persistent Properties of a Subpopulation of Cancer Cells Overexpressing the Hedgehog Receptor Patched.

Pharmaceutics. 2022-5-5

[6]
Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.

Endocr Pathol. 2022-3

[7]
CENPF/CDK1 signaling pathway enhances the progression of adrenocortical carcinoma by regulating the G2/M-phase cell cycle.

J Transl Med. 2022-2-5

[8]
Overexpression of SKA Complex Is Associated With Poor Prognosis in Gliomas.

Front Neurol. 2022-1-13

[9]
EMS1/DLL4-Notch Signaling Axis Augments Cell Cycle-Mediated Tumorigenesis and Progress in Human Adrenocortical Carcinoma.

Front Oncol. 2021-11-10

本文引用的文献

[1]
Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinoma.

Virchows Arch. 2020-6-12

[2]
Sterol O-Acyl Transferase 1 as a Prognostic Marker of Adrenocortical Carcinoma.

Cancers (Basel). 2020-1-19

[3]
Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosis.

Cancer Biol Med. 2019-11

[4]
Adrenal cortical carcinoma: pathology, genomics, prognosis, imaging features, and mimics with impact on management.

Abdom Radiol (NY). 2020-4

[5]
Loss of ATRX expression predicts worse prognosis in pulmonary carcinoid tumors.

Hum Pathol. 2019-9-6

[6]
Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system.

Gut. 2019-8-28

[7]
Effects of miR‑106b‑3p on cell proliferation and epithelial‑mesenchymal transition, and targeting of ZNRF3 in esophageal squamous cell carcinoma.

Int J Mol Med. 2019-2-25

[8]
A ZNRF3-dependent Wnt/β-catenin signaling gradient is required for adrenal homeostasis.

Genes Dev. 2019-1-28

[9]
Influence of hormonal functional status on survival in adrenocortical carcinoma: systematic review and meta-analysis.

Eur J Endocrinol. 2018-12-1

[10]
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.

Eur J Endocrinol. 2018-10-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索